JPRN-jRCT1050220114尚未招募Unknown
A multi-institutional three-step retrospective study to explore novel molecular biomarkers that indicate high-risk of recurrence in surgically-resected pStage I non-squamous NSCLC patients
Suda Kenichi0 个研究点目标入组 360 人开始时间: 2022年11月4日最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
- 入组人数
- 360
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Non-squamous NSCLC patients who received R0 resection
- •Pure solid tumor at preoperative CT examination
- •Patients who received lobectomy and mediastinal LN dissection
- •Pathologically confirmed stage I NSCLC
- •RNA sample is available (cohort 1)
- •RNA sequence data is available (cohort 2)
- •FFPE sample is available (cohort 3)
排除标准
- •Patients who received neoadjuvant therapy
- •Patients who died due to postoperative complication within 90 days after pulmonary resection
- •Patients with lost follow up within 5 years
- •In cohort3, patients who were enrolled in cohort 1 or cohort 2 will be excluded
研究者
相似试验
尚未招募
Unknown
A multi-institutional, retrospective, observational study on the healing course of post-operative hypersensitivity during extraction of mandibular wisdom teeth.Wisdom toothJPRN-UMIN000051080agasaki university280
招募中
不适用
A multi-center, cross-section, retrospectivestudy of TCM symptome characteristics of atherosclerotic myocardial infarctioAtherosclerotic myocardial infarctionITMCTR2200005906Zhejiang Chinese Medical University
招募中
不适用
Multi-institutional retrospective observational study of effectiveness and safety of treatment with Nivolmab for advanced or recurrent non-small cell lung cancer harboring EGFR mutation.JPRN-UMIN000025261HANSHIN Oncology Group100
已完成
不适用
A multi-institutional, retrospective, translational study of the relationship between histological immune-related signatures and clinical benefit of paclitaxel + bevacizumab therapy in HER2-negative advanced breast cancerHER2-negative advanced breast cancerJPRN-UMIN000041493The Mt.Fuji Foundation for Healthcare Innovation and Cluster Development Pharma Valley Center156
已完成
不适用
A Prospective, Multi-center, Three Year Follow-up Study on Endovascular Treatment for Infra-inguinal Vessel in patients with critical limb ischemia.Patients with peripheral artery disease (PAD) associated with critical limbs ischemia (CLI)JPRN-UMIN000014759OLIVE Registry Study Group229